performance of the listed companies. Whereas in the second quarter 2019, The Company had gain on sale of equity securities. The Company recognized share of profit from associates of Baht 24.06 million in this
to match with customer requirement which are the results from Sale department has contact new target customer group for expanding the Flexible packaging market. 4. Administrative expenses For Quarter2
Limited. (“ERV”) shall invest to purchase the newly issued ordinary share of ERV by 24,999 shares at the price of Baht 100 per share, total investment value is Baht 2,499,900 (par value of Baht 100 per
Revolution Company Limited. (“ERV”) shall invest to purchase the newly issued ordinary share of ERV by 24,999 shares at the price of Baht 100 per share, total investment value is Baht 2,499,900 (par value of
support businesses for a broader coverage. - Revise supervisory criteria for venture capital (VC) business, such as establishing investment ratio in financial technology (FinTech) business and extending VC
- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager
Bangkok Business Broadcasting Company Limited), a subsidiary in which the Company holds 149,900,002 ordinary shares with a par value of Baht 10 per share, equivalent to 99.9333 percent of total ordinary
personal expenses and the depreciation because of the expanding capacity of subsidiaries. Sincerely yours, (Mr.Pongpat Patanavanich) Managing Director
Consolidated net loss for the period (Q1) amount -4.57 million compare with the same period (Q1) for the last year amount -2.80 because the Company Cost of Market Development of Expanding the customer base and
operations & Administrative expenses increased by Baht 97.94 million or 6.79 % due to the Medical personal expenses which was in line with the increased revenue,also increased because of the expanding capacity